INS and Alzheimer disease: Micropeptide HN (Humanin) demonstrates multifaceted potential applications in the treatment of Alzheimer’s disease (AD), with mechanisms of action that include neuroprotection, antioxidant and anti-inflammatory effects, regulation of insulin sensitivity, inhibition of apoptosis, and maintenance of mitochondrial function (Figure 3).